Jörg D. Seebach

6.3k total citations
173 papers, 4.6k citations indexed

About

Jörg D. Seebach is a scholar working on Surgery, Immunology and Genetics. According to data from OpenAlex, Jörg D. Seebach has authored 173 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Surgery, 62 papers in Immunology and 38 papers in Genetics. Recurrent topics in Jörg D. Seebach's work include Xenotransplantation and immune response (80 papers), Immune Cell Function and Interaction (36 papers) and T-cell and B-cell Immunology (29 papers). Jörg D. Seebach is often cited by papers focused on Xenotransplantation and immune response (80 papers), Immune Cell Function and Interaction (36 papers) and T-cell and B-cell Immunology (29 papers). Jörg D. Seebach collaborates with scholars based in Switzerland, United States and Germany. Jörg D. Seebach's co-authors include Mårten K. J. Schneider, Georg Stüssi, Pietro Forte, Bettina C. Baumann, Robert Rieben, David H. Sachs, Urs Schanz, Gisella Puga Yung, Benjamin G. Lilienfeld and H DerSimonian and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jörg D. Seebach

156 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörg D. Seebach Switzerland 41 2.1k 1.6k 1.1k 686 641 173 4.6k
Robert Rieben Switzerland 36 1.7k 0.8× 927 0.6× 646 0.6× 656 1.0× 299 0.5× 149 3.8k
M. Abbal France 31 795 0.4× 1.2k 0.7× 425 0.4× 572 0.8× 673 1.0× 117 4.5k
Christine Bodemer France 47 973 0.5× 2.0k 1.2× 1.4k 1.3× 2.2k 3.2× 1.3k 2.0× 309 8.2k
Sophie Caillat‐Zucman France 50 1.2k 0.5× 4.1k 2.6× 1.6k 1.4× 1.3k 1.9× 1.4k 2.2× 191 7.8k
Joren C. Madsen United States 44 3.0k 1.4× 2.2k 1.4× 351 0.3× 930 1.4× 712 1.1× 221 6.1k
Yuichi Iwaki United States 23 1.2k 0.5× 785 0.5× 564 0.5× 518 0.8× 274 0.4× 66 3.0k
Sabine Sarnacki France 37 1.9k 0.9× 1.5k 0.9× 280 0.3× 1.1k 1.6× 556 0.9× 211 5.4k
Helge Scott Norway 39 1.8k 0.8× 2.5k 1.6× 1.1k 1.0× 620 0.9× 2.7k 4.2× 117 6.9k
John C. Papadimitriou United States 46 1.9k 0.9× 1.2k 0.8× 441 0.4× 1.4k 2.1× 730 1.1× 213 7.9k
J. J. van Rood Netherlands 40 894 0.4× 3.6k 2.3× 903 0.8× 531 0.8× 915 1.4× 188 6.3k

Countries citing papers authored by Jörg D. Seebach

Since Specialization
Citations

This map shows the geographic impact of Jörg D. Seebach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg D. Seebach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg D. Seebach more than expected).

Fields of papers citing papers by Jörg D. Seebach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg D. Seebach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg D. Seebach. The network helps show where Jörg D. Seebach may publish in the future.

Co-authorship network of co-authors of Jörg D. Seebach

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg D. Seebach. A scholar is included among the top collaborators of Jörg D. Seebach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg D. Seebach. Jörg D. Seebach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bréville, Gautier, et al.. (2022). Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach. Swiss Medical Weekly. 152(102). w30088–w30088. 28 indexed citations
3.
Meyer, Philippe, et al.. (2022). Péricardite récurrente idiopathique : revue de littérature et expérience genevoise. Revue Médicale Suisse. 18(776). 660–668.
4.
Spoerl, David, et al.. (2021). Three cases of BRAF mutation negative Erdheim-Chester disease with a challenging distinction from IgG4-related disease. Allergy Asthma and Clinical Immunology. 17(1). 6–6. 3 indexed citations
6.
Moll, Solange, et al.. (2019). [IgG4 related disease : the Geneva experience].. PubMed. 15(645). 736–741.
7.
Seebach, Jörg D., et al.. (2016). Comprendre les immunodéficiences primaires avec un registre. Archive ouverte UNIGE (University of Geneva). 1 indexed citations
8.
Schneider, Mårten K. J. & Jörg D. Seebach. (2012). Xenotransplantation literature update, November–December 2011. Xenotransplantation. 19(1). 65–69. 1 indexed citations
9.
Müller, Yannick D., Gang Mai, Philippe Morel, et al.. (2010). Anti-CD154 mAb and Rapamycin Induce T Regulatory Cell Mediated Tolerance in Rat-to-Mouse Islet Transplantation. PLoS ONE. 5(4). e10352–e10352. 39 indexed citations
10.
Yung, Gisella Puga, Mårten K. J. Schneider, & Jörg D. Seebach. (2009). Immune responses to α1,3 galactosyltransferase knockout pigs. Current Opinion in Organ Transplantation. 14(2). 154–160. 21 indexed citations
11.
Schneider, Mårten K. J., John D. Lambris, Paola Magotti, et al.. (2008). Cytokine Secretion Depends on Galα(1,3)Gal Expression in a Pig-to-Human Whole Blood Model. The Journal of Immunology. 180(9). 6346–6353. 25 indexed citations
12.
Forte, Pietro, Benjamin G. Lilienfeld, Bettina C. Baumann, & Jörg D. Seebach. (2005). Human NK Cytotoxicity against Porcine Cells Is Triggered by NKp44 and NKG2D. The Journal of Immunology. 175(8). 5463–5470. 60 indexed citations
13.
Baumann, Bettina C., Pietro Forte, Robert J. Hawley, et al.. (2004). Lack of Galactose-α-1,3-Galactose Expression on Porcine Endothelial Cells Prevents Complement-Induced Lysis but Not Direct Xenogeneic NK Cytotoxicity. The Journal of Immunology. 172(10). 6460–6467. 70 indexed citations
14.
Shah, Cyril, Jürg Böni, Leslie R. Bisset, Jörg D. Seebach, & Jörg Schüpbach. (2003). Ultra-sensitive and specific detection of porcine endogenous retrovirus (PERV) using a sequence-capture real-time PCR approach. Journal of Virological Methods. 109(2). 209–216. 10 indexed citations
15.
Stüssi, Georg, Jörg Muntwyler, Jakob Passweg, et al.. (2002). Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 30(2). 87–93. 85 indexed citations
16.
Köcher, Markus, et al.. (2002). Rolling adhesion of human NK cells to porcine endothelial cells mainly relies on CD49d-CD106 interactions1. Transplantation. 73(5). 789–796. 30 indexed citations
17.
18.
Forte, Pietro, et al.. (2001). HLA-G Inhibits Rolling Adhesion of Activated Human NK Cells on Porcine Endothelial Cells. The Journal of Immunology. 167(10). 6002–6008. 64 indexed citations
19.
Brander, Christian, Todd J. Suscovich, Yun Jung Lee, et al.. (2000). Impaired CTL Recognition of Cells Latently Infected with Kaposi’s Sarcoma-Associated Herpes Virus. The Journal of Immunology. 165(4). 2077–2083. 70 indexed citations
20.
Fuchimoto, Yasushi, Christene A. Huang, Akira Shimizu, et al.. (1999). An allelic non‐histocompatibility antigen with wide tissue distribution as a marker for chimerism in pigs. Tissue Antigens. 54(1). 43–52. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026